GOLDENWELL BIOTECH, INC. (GWLL) Shareholders’ equity 2019–2025
GOLDENWELL BIOTECH, INC. (GWLL) shareholders’ equity at each fiscal year-end, per SEC filings.
-$343,713FY2025 · since FY2019: $246,593 → -$343,713
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$343,713 | -627.6% |
| FY2024 | -$47,241 | -156.1% |
| FY2023 | $84,257 | -58.2% |
| FY2022 | $201,618 | -33.2% |
| FY2021 | $301,713 | +21.4% |
| FY2020 | $248,569 | +0.8% |
| FY2019 | $246,593 | — |
Source: SEC XBRL filings · For reference only · Not investment advice